A novel RFX6 heterozygous mutation (p.R652X) in maturity-onset diabetes mellitus: A case report

J Diabetes Investig. 2021 Oct;12(10):1914-1918. doi: 10.1111/jdi.13545. Epub 2021 Apr 9.

Abstract

Heterozygous RFX6 mutation has emerged as a potential cause of maturity-onset diabetes mellitus of the young (MODY). A 16-year-old female was diagnosed with diabetes by her family doctor and was referred to our institution for genetic examination. Genetic testing revealed a novel RFX6 heterozygous mutation (NM_173560: exon17: c.1954C>T: p.R652X) in the patient and in her mother and brother. She had no islet-specific autoantibodies and showed a reduced meal-induced response of insulin, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide-1, which is consistent with the phenotype of MODY due to heterozygous RFX6 mutation. In conclusion, we report a case of MODY due to a novel heterozygous mutation, p.R652X.

Keywords: GIP; GLP-1; RFX6.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / genetics*
  • Female
  • Humans
  • Mutation
  • Pedigree
  • Regulatory Factor X Transcription Factors / genetics*

Substances

  • Regulatory Factor X Transcription Factors
  • Rfx6 protein, human

Supplementary concepts

  • Mason-Type Diabetes